Skip to content
Life Sciences Series B Founded 2006

Hangzhou Lianchuan Biotechnology

Provider of genetic testing services. The service portfolio of the company includes Genome Sequencing, Genome Heavy Sequencing, Exome Sequencing, Genetic Mapping, BSA Characterization, Transcriptome Sequencing, Three-Generation Full-Length Transcriptome Sequencing, Single-Cell Transcriptome Sequencing, and other services. Operating in the Life Sciences > Life Sciences Platforms and Tools, Life Sciences > Genomics…

📍 Hangzhou, China · Life Sciences Platforms and Tools,

Funding snapshot

Last roundSeries B
Amount$26M
Date12 October 2021
Total raised$26M

About

Provider of genetic testing services. The service portfolio of the company includes Genome Sequencing, Genome Heavy Sequencing, Exome Sequencing, Genetic Mapping, BSA Characterization, Transcriptome Sequencing, Three-Generation Full-Length Transcriptome Sequencing, Single-Cell Transcriptome Sequencing, and other services. Operating in the Life Sciences > Life Sciences Platforms and Tools, Life Sciences > Genomics sector. with business models spanning Genomics > Genomics Services > Sequencing, Life Sciences Platforms and Tools > Research Services > Genomics. Founded in 2006, headquartered in Hangzhou, China. The company has raised $25.8M at the Series B stage, backed by investors including Zhejiang Huarui Investment Holdings, ZSVC, Rushan Capital, Zhejiang Haibang Investment Management, Hangzhou Jinju Investment Management.

Business model

Genomics > Genomics Services > Sequencing,

Life Sciences Platforms and Tools > Research Services > Genomics

Institutional investors

Zhejiang Huarui Investment Holdings ZSVC Rushan Capital Zhejiang Haibang Investment Management Hangzhou Jinju Investment Management Chengdu Haiyue Investment Management

Latest coverage

No articles yet.

Raising like Hangzhou Lianchuan Biotechnology?

Analyze your pitch deck before your next raise.

Analyze My Deck →